Comparative Antimicrobial Susceptibility Profiling of Tigecycline and Other Antibiotics against Clinical and Environmental Isolates (original) (raw)
Microbial isolation and emergence of antimicrobial resistance associated with tigecycline usage
Tun-chieh Chen
Journal of Microbiology, Immunology and Infection, 2011
View PDFchevron_right
In vitro activity of tigecycline against local clinical isolates of some Enterobacteriaceae
Hisham Abbas
Zagazig Journal of Pharmaceutical Sciences
View PDFchevron_right
A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae
angel cooper
Journal of Antimicrobial Chemotherapy, 2008
View PDFchevron_right
Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies
Xavier Guirao
Journal of Antimicrobial Chemotherapy, 2013
View PDFchevron_right
Antibiotic Susceptibility Profile of Gram-Negative Isolates from Wound Swabs
Kome Otokunefor
Zenodo (CERN European Organization for Nuclear Research), 2019
View PDFchevron_right
Evaluation of the in vitro activity of tigecycline against multiresistant Gram-positive cocci containing tetracycline resistance determinants
Floriana Campanile
International Journal of Antimicrobial Agents, 2008
View PDFchevron_right
Population Pharmacokinetics of Tigecycline in Critically Ill Patients with Severe Infections
Dr. Abdulaziz S Al Obaid
Antimicrobial Agents and Chemotherapy, 2017
View PDFchevron_right
AN IN-VITRO STUDY OF TIGECYCLINE SUSCEPTIBILITY AMONG MULTIDRUG RESISTANT BACTERIA IN A TERTIARY CARE HOSPITAL
Scholar Science Journals
View PDFchevron_right
Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studies
Xavier Guirao
Journal of Antimicrobial Chemotherapy, 2013
View PDFchevron_right
Tigecycline susceptibility among multi-drug resistant bacteria: A 7-year retrospective study
Kenza El Bazi
GSC Advanced Research and Reviews
View PDFchevron_right
Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline
F. Rossi
Journal of Antimicrobial Chemotherapy, 2007
View PDFchevron_right
Antibiotic Consumption, Resistance Data, and Prevention Strategies
Aliye Baştuğ
Mediterranean Journal of Infection Microbes and Antimicrobials, 2019
View PDFchevron_right
A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections
Vitoon Chinswangwatanakul
BMC Infectious Diseases, 2012
View PDFchevron_right
Trends in the Susceptibility of Clinically Important Resistant Bacteria to Tigecycline: Results from the Tigecycline In Vitro Surveillance in Taiwan Study, 2006 to 2010
Ming-hsun Lee
Antimicrobial Agents and Chemotherapy, 2011
View PDFchevron_right
Tigecycline susceptibility report from an Indian tertiary care hospital
Bijayini Behera
View PDFchevron_right
In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints
Joseph Papaparaskevas
Diagnostic Microbiology and Infectious Disease, 2010
View PDFchevron_right
Resistance trends and in vitro activity of tigecycline and 17 other antimicrobial agents against Gram-positive and Gram-negative organisms, including multidrug-resistant pathogens, in Germany
Karsten Becker
European Journal of Clinical Microbiology & Infectious Diseases, 2011
View PDFchevron_right
Antimicrobial activity of tigecycline against clinical isolates from Spanish medical centers. Second multicenter study
Fatima Lopez
Diagnostic Microbiology and Infectious Disease, 2006
View PDFchevron_right
Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review
farajolah maleki
European Journal of Clinical Microbiology & Infectious Diseases
View PDFchevron_right
Susceptibility to Tigecycline of Multiresistant Bacteria at Ibn Rochd University Hospital-Casablanca
assiya el kettani
2019
View PDFchevron_right
Sensitivity Testing of Antibiotics: A Brief Review
Keshav Jindal
Annals of Tropical Medicine and Public Health, 2020
View PDFchevron_right
Tigecycline: A New Treatment Choice Against Acinetobacter baumannii
Virginia Bosó Ribelles
Recent Patents on Anti-Infective Drug Discovery, 2008
View PDFchevron_right
Antibiotic treatment and the risk of antibiotic resistance
bajram tershani
2017
View PDFchevron_right
Spectrum and Drug Susceptibility Profile of Bacteria Recovered from Patients with Wound Infection Referred to Arsho Advanced Medical Laboratory
mesele admassie
Clinical Medicine Research, 2018
View PDFchevron_right
In-vitro activity of tigecycline against multidrug-resistant Gram negative bacteria: The experience of a university hospital
Nasser Kaplan
Journal of Infection and Public Health, 2021
View PDFchevron_right
Agreement Assessment of Tigecycline Susceptibilities Determined by the Disk Diffusion and Broth Microdilution Methods among Commonly Encountered Resistant Bacterial Isolates: Results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) Study, 2008 to 2010
Po-ren Hsueh, Ming-hsun Lee
Antimicrobial Agents and Chemotherapy, 2012
View PDFchevron_right
Antimicrobial susceptibility trends among gram‑positive and ‑negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial
Letícia M. Nievola
View PDFchevron_right
Tetracycline susceptibility in multidrug resistant Staphylococcus aureus isolated from clinical samples in tertiary care hospitals of Kathmandu, Nepal
Lata Ghimire
The harvest, 2024
View PDFchevron_right
Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centers
Ronald Jones
Diagnostic Microbiology and Infectious Disease, 2008
View PDFchevron_right
A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms …
Krasimir Vasilev
Journal of …, 2008
View PDFchevron_right
Investigation of the prevalence of tetQ, tetX and tetX1 genes in Bacteroides strains with elevated tigecycline minimum inhibitory concentrations
Elisabeth Nagy
International Journal of Antimicrobial Agents, 2011
View PDFchevron_right
In Vitro Activity of Tigecycline against Multiple-Drug-Resistant, Including Pan-Resistant, Gram-Negative and Gram-Positive Clinical Isolates from Greek Hospitals
Efthymia Giannitsioti
Antimicrobial Agents and Chemotherapy, 2006
View PDFchevron_right